6533b7d9fe1ef96bd126c47a

RESEARCH PRODUCT

Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory markers: a preliminary report.

Antonino GiarratanoSalvatore MangioneG Cuccio

subject

medicine.medical_specialtyEclampsiaProteinuriabusiness.industryHELLP syndromeAntithrombinCritical Care and Intensive Care Medicinemedicine.diseaseBioinformaticsGastroenterologyCoagulationPreliminary reportInternal medicineMeeting AbstractMedicinemedicine.symptombusinessmedicine.drughttp://europepmc.org/abstract/PMC/PMC3332953